1. Sekimoto M, Kokunai I, Shimano T, Kobayashi T, Takeda T, Haruna N, Yamamoto A, Mori T. Production of tumor necrosis factor(TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma. J Clin Lab Immunol. 1988; 27: 115–20.
2. Haruna N, Monden T, Morimoto H, Murotani M, Yagyu T, Nagaoka H, Shimano T, Mori T. Use of a rapid microwave fixation technique for immunocytochemical demonstration of tumor necrosis factor, interleukin-1a, and interleukin-1b in activated human peripheral mononuclear cells. Acta Histochem Cytochem. 1990; 23: 563–72.
3. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. New approach to management of malignant ascites with a Streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Surgery 1983; 93: 357–64.
4. Katano M, Torisu M. New approach to management of malignant ascites with a Streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction, Surgery 1983; 93: 365–73.
5. Watanabe Y, Iwa T. Clinical value of immunotherapy for lung cancer by the Streptococcal preparation OK-432. Cancer 1984; 53: 248–53.